Glaukos Corporation (GKOS) Financials
GKOS Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 940.4 million | 478.6 million |
2023-09-30 | 948.6 million | 471.0 million |
2023-06-30 | 956.7 million | 467.9 million |
2023-03-31 | 972.6 million | 464.1 million |
GKOS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -14.9 million | 13.0 million |
2023-09-30 | -11.5 million | 10.5 million |
2023-06-30 | -13.9 million | 9.9 million |
2023-03-31 | -37.7 million | 10.2 million |
GKOS Net Income
No data available :(
GKOS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 295.4 million | - | 101.0 million |
2023-09-30 | 300.9 million | - | 101.4 million |
2023-06-30 | 303.8 million | - | 101.8 million |
2023-03-31 | 317.8 million | - | 101.5 million |
GKOS Shares Outstanding
GKOS Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 4.2 million | 39.1 million | 63.0 million | - |
2023-09-30 | 3.4 million | 33.3 million | 54.2 million | - |
2023-06-30 | 5.8 million | 36.2 million | 53.1 million | - |
2023-03-31 | 6.9 million | 35.2 million | 53.7 million | - |
GKOS Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 82.4 million | 18.9 million |
2023-09-30 | 78.0 million | 18.5 million |
2023-06-30 | 80.4 million | 20.1 million |
2023-03-31 | 73.9 million | 18.1 million |
GKOS
Price: $98.91
52 week price:
Earnings Per Share: -2.78 USD
P/E Ratio: -35.68
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Volume: 62314
Ebitda: 2.3 millionMarket Capitalization: 5.0 billion